CoChat

Probiotic use in irritable bowel syndrome

Young, Patrick, Cash, Brooks D. · 2006 · Current Gastroenterology Reports

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Abstract

Over the past several years, a number of studies have addressed the role of specific strains of bacteria, or combinations thereof, to alleviate certain symptoms of irritable bowel syndrome (IBS). More importantly, the precise factors that contribute to this therapeutic effect, such as modulations in cytokine levels and alterations in colonic motility, are being clarified. This review serves to summarize the evidence for the use of probiotics in the treatment of IBS and to place this information in clinical context. Potential future developments and areas of possible research are also discussed.

Overview

Integrity signals

Registry

Crossref · 10.1007/s11894-006-0053-1

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 47 references

Cited by

See all 24

Metadata

Authors
Young, P., & Cash, B. D.
Affiliations
Walter Reed National Military Medical Center (US)
Corresponding author
Young, Patrick
Venue
Current Gastroenterology Reports
Published
2006-07
Volume
8
Issue
4
Pages
321-326
ISSN
  • 1522-8037 (ISSN-L)
  • 1534-312X
OpenAlex
W2090988461
Cited by
22
References
47
Citations by year
2022: 2 · 2021: 1 · 2020: 1 · 2018: 1 · 2014: 2 · 2013: 1
FWCI
0.64
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Current Gastroenterology Reports (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
probiotics, irritable bowel syndrome, bacterial strain, cytokines, colonic motility, probiotic therapy
MeSH terms
Humans, Treatment Outcome, Probiotics, Irritable Bowel Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Probiotic use in irritable bowel syndrome. https://app.cochat.ai/papers/10.1007/s11894-006-0053-1
The paper
Young, P., & Cash, B. D. (2006). Probiotic use in irritable bowel syndrome. Current Gastroenterology Reports. https://doi.org/10.1007/s11894-006-0053-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.